Ovid Therapeutics Inc. 8-K Filing

Ticker: OVID · Form: 8-K · Filed: Dec 18, 2025 · CIK: 1636651

Ovid Therapeutics Inc. 8-K Filing Summary
FieldDetail
CompanyOvid Therapeutics Inc. (OVID)
Form Type8-K
Filed DateDec 18, 2025
Pages1
Reading Time2 min
Key Dollar Amounts$0.001
Sentimentneutral

Sentiment: neutral

FAQ

What type of filing is this?

This is a 8-K filing submitted by Ovid Therapeutics Inc. (ticker: OVID) to the SEC on Dec 18, 2025.

What are the key financial figures in this filing?

Key dollar amounts include: $0.001 (hich registered Common Stock par value $0.001 per share OVID The Nasdaq Stock Mar).

How long is this filing?

Ovid Therapeutics Inc.'s 8-K filing is 1 pages with approximately 434 words. Estimated reading time is 2 minutes.

Where can I view the full 8-K filing?

The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.

Filing Stats: 434 words · 2 min read · ~1 pages · Grade level 10.3 · Accepted 2025-12-18 08:39:41

Key Financial Figures

  • $0.001 — hich registered Common Stock par value $0.001 per share OVID The Nasdaq Stock Mar

Filing Documents

Financial Statements and Exhibits

Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press Release, dated December 18, 2025. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized Date: December 18, 2025 OVID THERAPEUTICS INC. By: /s/ Jeffrey Rona Jeffrey Rona Chief Business and Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.